AU8626398A - Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis - Google Patents

Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis

Info

Publication number
AU8626398A
AU8626398A AU86263/98A AU8626398A AU8626398A AU 8626398 A AU8626398 A AU 8626398A AU 86263/98 A AU86263/98 A AU 86263/98A AU 8626398 A AU8626398 A AU 8626398A AU 8626398 A AU8626398 A AU 8626398A
Authority
AU
Australia
Prior art keywords
phosphodiesterase
inhibitors
treatment
allergic rhinitis
rhinitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86263/98A
Inventor
Jurgen Engel
Norbert Hofgen
Degenhard Marx
Hildegard Poppe
Stefan Szelenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AWD Pharma GmbH and Co KG
Original Assignee
Arzneimittelwerk Dresden GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden GmbH filed Critical Arzneimittelwerk Dresden GmbH
Publication of AU8626398A publication Critical patent/AU8626398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU86263/98A 1997-07-03 1998-06-12 Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis Abandoned AU8626398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19728301A DE19728301A1 (en) 1997-07-03 1997-07-03 Use of inhibitors of phosphodiesterase 4 for the treatment of allergic rhinitis
DE19728301 1997-07-03
PCT/EP1998/003561 WO1999001134A1 (en) 1997-07-03 1998-06-12 Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
AU8626398A true AU8626398A (en) 1999-01-25

Family

ID=7834441

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86263/98A Abandoned AU8626398A (en) 1997-07-03 1998-06-12 Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis

Country Status (6)

Country Link
AR (1) AR016308A1 (en)
AU (1) AU8626398A (en)
CA (1) CA2241879A1 (en)
DE (1) DE19728301A1 (en)
WO (1) WO1999001134A1 (en)
ZA (1) ZA985481B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (en) * 2000-03-14 2001-09-20 Dresden Arzneimittel Treating erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, as cGMP-selective phosphodiesterase V inhibitors free of cardiovascular side-effects
CN113016634B (en) * 2021-04-16 2023-07-21 安徽省农业科学院农产品加工研究所 Method for preparing urethra-protecting cat litter by utilizing mixed fermentation of probiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases

Also Published As

Publication number Publication date
CA2241879A1 (en) 1999-01-03
ZA985481B (en) 1998-08-25
WO1999001134A1 (en) 1999-01-14
DE19728301A1 (en) 1999-01-07
AR016308A1 (en) 2001-07-04

Similar Documents

Publication Publication Date Title
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
SI1231920T1 (en) Use of epinastin for the treatment of allergic rhinitis/conjunctivitis
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU4061597A (en) Treatment of the common cold or allergic rhinitis
AU6910600A (en) Methods for the treatment of mental disorders
IL127496A0 (en) The use of MMP inhibitors for the treatment of ocular angiogenesis
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU4694999A (en) Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
AU1697197A (en) Immunoconjugate for the treatment of aids
AU7750100A (en) Method for the treatment of obesity
AU1878201A (en) Composition for the treatment of damaged tissue
AU8626398A (en) Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU5792398A (en) Leukotriene antagonists for treatment or inhibition of gout
AU2566201A (en) Compounds and methods for the treatment of pain
AU4032799A (en) Device for the treatment of bottles
AU2420101A (en) Method and composition for the treatment of pain
AU1103699A (en) Use of an inhibitor of the dephosphorylation of darpp-32 for treating schizophrenia
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU2683500A (en) Compositions for the treatment of pain
AU7709400A (en) Methods of use of fluoroquinolone compounds against bacteria
AU6947900A (en) Methods of use of fluoroquinolone compounds against bacteria
AU2382601A (en) Novel method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase